Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 02:12PM ET
11.48
Dollar change
+0.20
Percentage change
1.77
%
IndexRUT P/E- EPS (ttm)-1.62 Insider Own65.80% Shs Outstand158.83M Perf Week-1.12%
Market Cap1.83B Forward P/E- EPS next Y-1.58 Insider Trans0.00% Shs Float54.56M Perf Month29.72%
Income-254.02M PEG- EPS next Q-0.37 Inst Own20.41% Short Float13.39% Perf Quarter12.77%
Sales0.00M P/S- EPS this Y59.15% Inst Trans- Short Ratio9.18 Perf Half Y-19.44%
Book/sh2.66 P/B4.31 EPS next Y-6.52% ROA-60.32% Short Interest7.30M Perf Year-
Cash/sh2.65 P/C4.33 EPS next 5Y- ROE-64.28% 52W Range8.33 - 21.00 Perf YTD-32.67%
Dividend Est.- P/FCF- EPS past 5Y- ROI-59.70% 52W High-45.33% Beta-
Dividend TTM- Quick Ratio17.99 Sales past 5Y0.00% Gross Margin- 52W Low37.82% ATR (14)0.66
Dividend Ex-Date- Current Ratio17.99 EPS Y/Y TTM-99.66% Oper. Margin0.00% RSI (14)60.29 Volatility6.16% 6.63%
Employees124 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price23.26
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-43.81% Payout- Rel Volume0.43 Prev Close11.28
Sales Surprise- EPS Surprise0.58% Sales Q/Q- EarningsMay 07 BMO Avg Volume795.38K Price11.48
SMA2011.02% SMA5015.83% SMA200-10.02% Trades Volume251,192 Change1.77%
Date Action Analyst Rating Change Price Target Change
TodayInitiated Needham Buy $23
Jul-08-24Initiated Mizuho Outperform $20
Dec-12-23Initiated Deutsche Bank Hold $13
Oct-10-23Initiated William Blair Outperform $26
Oct-10-23Initiated Stifel Buy $26
Oct-10-23Initiated RBC Capital Mkts Outperform $24
Oct-10-23Initiated JP Morgan Overweight $21
Oct-10-23Initiated Guggenheim Buy $22
Oct-10-23Initiated BofA Securities Buy $18
Jul-01-24 01:00AM
Jun-20-24 07:00AM
May-14-24 08:52AM
07:00AM
May-07-24 01:54PM
10:20AM Loading…
10:20AM
07:00AM
May-06-24 07:00AM
Apr-16-24 11:28AM
Apr-15-24 04:20PM
12:17PM
08:45AM
07:47AM
06:36AM
06:30AM
07:00AM Loading…
Mar-13-24 07:00AM
Mar-07-24 02:52PM
07:00AM
Jan-22-24 07:00AM
Jan-10-24 08:32AM
Jan-02-24 07:00AM
Dec-17-23 12:35PM
Dec-12-23 07:00AM
Nov-27-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
Oct-10-23 07:00AM
Sep-28-23 07:54PM
Sep-27-23 06:50PM
Sep-18-23 12:35PM
08:49PM Loading…
Sep-14-23 08:49PM
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burow KristinaDirectorNov 14 '23Buy11.983,35740,2174,131,207Nov 15 06:55 PM
ARCH Venture Partners XII, LLC10% OwnerNov 14 '23Buy11.983,35740,2174,131,207Nov 15 06:54 PM
ARCH Venture Partners XII, LLC10% OwnerNov 13 '23Buy11.7531,653371,9234,127,850Nov 15 06:54 PM
Burow KristinaDirectorNov 13 '23Buy11.7531,653371,9234,127,850Nov 15 06:55 PM
Burow KristinaDirectorNov 10 '23Buy11.4917,275198,4814,096,197Nov 13 07:01 PM
ARCH Venture Partners XII, LLC10% OwnerNov 10 '23Buy11.4917,275198,4814,096,197Nov 13 07:00 PM
ARCH Venture Partners XII, LLC10% OwnerNov 09 '23Buy10.5331,079327,2624,078,922Nov 13 07:00 PM
Burow KristinaDirectorNov 09 '23Buy10.5331,079327,2624,078,922Nov 13 07:01 PM
Burow KristinaDirectorNov 08 '23Buy11.0392,2511,017,8214,047,843Nov 13 07:01 PM
ARCH Venture Partners XII, LLC10% OwnerNov 08 '23Buy11.0392,2511,017,8214,047,843Nov 13 07:00 PM
Burow KristinaDirectorNov 07 '23Buy11.5030,192347,2083,955,592Nov 07 07:00 PM
ARCH Venture Partners XII, LLC10% OwnerNov 07 '23Buy11.5030,192347,2083,955,592Nov 07 06:59 PM
ARCH Venture Partners XII, LLC10% OwnerNov 06 '23Buy11.5543,082497,5973,925,400Nov 07 06:59 PM
Burow KristinaDirectorNov 06 '23Buy11.5543,082497,5973,925,400Nov 07 07:00 PM
Burow KristinaDirectorNov 03 '23Buy11.3822,420255,1403,882,318Nov 07 07:00 PM
ARCH Venture Partners XII, LLC10% OwnerNov 03 '23Buy11.3822,420255,1403,882,318Nov 07 06:59 PM
Burow KristinaDirectorSep 29 '23Buy13.9834,560483,1493,859,898Sep 29 06:55 PM
ARCH Venture Partners XII, LLC10% OwnerSep 29 '23Buy13.9834,560483,1493,859,898Sep 29 06:53 PM
ARCH Venture Partners XII, LLC10% OwnerSep 28 '23Buy13.4441,951563,6993,825,338Sep 29 06:53 PM
Burow KristinaDirectorSep 28 '23Buy13.4441,951563,6993,825,338Sep 29 06:55 PM
ARCH Venture Partners XII, LLC10% OwnerSep 27 '23Buy12.3124,504301,6443,783,387Sep 27 08:18 PM
Burow KristinaDirectorSep 27 '23Buy12.3124,504301,6443,783,387Sep 27 08:19 PM
Burow KristinaDirectorSep 26 '23Buy11.7334,000398,8203,758,883Sep 27 08:19 PM
ARCH Venture Partners XII, LLC10% OwnerSep 26 '23Buy11.7334,000398,8203,758,883Sep 27 08:18 PM
Burow KristinaDirectorSep 25 '23Buy11.2260,740681,4643,724,883Sep 25 09:37 PM
ARCH Venture Partners XII, LLC10% OwnerSep 25 '23Buy11.2260,740681,4643,724,883Sep 25 09:38 PM
ARCH Venture Partners XII, LLC10% OwnerSep 22 '23Buy11.1440,000445,6003,664,143Sep 25 09:38 PM
Burow KristinaDirectorSep 22 '23Buy11.1440,000445,6003,664,143Sep 25 09:37 PM
AMGEN INC10% OwnerSep 19 '23Buy17.001,764,70529,999,98535,368,653Sep 19 07:52 PM
Burow KristinaDirectorSep 19 '23Buy17.001,500,00025,500,0003,624,143Sep 20 06:23 AM
ARCH Venture Partners X, LLC10% OwnerSep 19 '23Buy17.001,500,00025,500,0003,624,143Sep 20 06:16 AM
ARCH Venture Partners X, LLC10% OwnerSep 19 '23Buy17.001,500,00025,500,0003,624,143Sep 20 06:15 AM
Gosebruch Henry OPresident & CEOSep 19 '23Buy12.6215,000189,37015,000Sep 19 09:47 PM